Proteomics in translational cancer research: Biomarker discovery for clinical applications

Expert Review of Proteomics

Volumn 11, Issue 2, 2014, Pages 131-133

  Cho, William C S ^a  

^a Local Health Authority   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; CARCINOEMBRYONIC ANTIGEN; GLYCOPROTEIN; GLYCOSYLATED PROTEIN; TRANSGELIN; PROTEOME; TUMOR MARKER;

CANCER MORTALITY; CANCER RESEARCH; CARCINOGENESIS; EXOSOME; GENOMICS; HUMAN; KIDNEY CARCINOMA; MASS SPECTROMETRY; NASOPHARYNX CARCINOMA; NEOPLASM; PROSTATE CANCER; PROTEOMICS; REVIEW; TRANSLATIONAL RESEARCH; TREATMENT OUTCOME; METABOLISM; PATHOLOGY; PROCEDURES; TUMOR EMBOLISM;

HUMANS; NEOPLASMS; NEOPLASTIC CELLS, CIRCULATING; PROTEOME; PROTEOMICS; TRANSLATIONAL MEDICAL RESEARCH; TUMOR MARKERS, BIOLOGICAL;

EID: 84896930691     PISSN: 14789450     EISSN: 17448387     Source Type: Journal    
DOI: 10.1586/14789450.2014.899908     Document Type: Review

References (13)

1. GLOBOCAN 2012: estimated cancer incidence, mortality and prevalence worldwide in 2012. Available from: http:// globocan.iarc.fr/Pages/fact-sheets- cancer. aspx
2. Gupta S, Venkatesh A, Ray S, Srivastava S. Challenges and prospects for biomarker research: A current perspective from the developing world. Biochim Biophys Acta 2014;pii:S1570-9639(14)00002-8
3. Smith RA, Brooks D, Cokkinides V, et al. Cancer screening in the United States, 2013: a review of current American Cancer Society guidelines, current issues in cancer screening, and new guidance on cervical cancer screening and lung cancer screening. CA Cancer J Clin 2013;63(2):88-105
4. Li D, Chan DW. Proteomic cancer biomarkers from discovery to approval: it's worth the effort. Expert Rev Proteomics 2014;11(2):135-6
5. Wang K, Huang C, Nice EC. Proteomics, genomics and transcriptomics: their emerging roles in the discovery and validation of colorectal cancer biomarkers. Expert Rev Proteomics 2014;11(2):179-205
6. Drake RR, Kislinger T. The proteomics of prostate cancer exosomes. Expert Rev Proteomics 2014;11(2):167-77
7. Cremona M, Espina V, Caccia D, et al. Stratification of clear cell renal cell carcinoma by signaling pathway analysis. Expert Rev Proteomics 2014;11(2):237-49
8. Xiao L, Xiao T, Wang Z-M, et al. Biomarker discovery of nasopharyngeal carcinoma by proteomics. Expert Rev Proteomics 2014;11(2):215-25
9. Dvorakova M, Nenutil R, Bouchal P. Transgelins, cytoskeletal proteins implicated in different aspects of cancer development. Expert Rev Proteomics 2014;11(2):149-65
10. Ludwig JA, Weinstein JN. Biomarkers in cancer staging, prognosis and treatment selection. Nat Rev Cancer 2005;5(11): 845-56
11. Badr HA, AlSadek DMM, Darwish AA, et al. Lectin approaches for glycoproteomics in FDA-approved cancer biomarkers. Expert Rev Proteomics 2014;11(2):227-36
12. Skvortsov S, Debbage P, Cho WCS, et al. Putative biomarkers and therapeutic targets associated with radiation resistance. Expert Rev Proteomics 2014;11(2):207-14
13. Chambers AG, Percy AJ, Simon R, Borchers CH. MRM for the verification of cancer biomarker proteins: recent applications to human plasma and serum. Expert Rev Proteomics 2014;11(2):137-48